Dr. Mohammad Akram Akram Kawsara, MD

Dr. Kawsara practices at Methodist Dallas Medical Center in Dallas, Texas, part of Methodist Hospitals of Dallas.

Dr. Kawsara's NPI, 1154636405, was assigned on August 11, 2010. Dr. Kawsara graduated from University of Aleppo Faculty of Medicine in 2006. Dr. Kawsara's Texas license number on file is V3027.

Dr. Kawsara's primary practice is Methodist Dallas Medical Center, at 1441 North Beckley Avenue, Dallas, TX 75203 in Dallas County. The practice phone is (214) 947-8181.

Dr. Kawsara's primary practice is Methodist Dallas Medical Center in Dallas, Texas, part of Methodist Hospitals of Dallas. Dr. Kawsara is also affiliated with Methodist Mansfield Medical Center. The medical group on file is Methodist Medical Group. Dmand AI also links Dr. Kawsara to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kawsara practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kawsara's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kawsara is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Kawsara's licenses on file in 3 states: Texas, West Virginia and Pennsylvania.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, chronic hypertension, coronary artery disease, heart valve disorders and heart valve surgery among the conditions Dr. Kawsara treats.

CMS data shows 576 Medicare services from Dr. Kawsara across 15 procedure codes in 2024, for 338 Medicare patients. Medicare paid $85,220 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 338 Medicare patients who saw Dr. Kawsara in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kawsara's median patient age at 70, with 47% women.

In 2024, Dr. Kawsara wrote 146 Medicare Part D claims for 61 patients. 84% of them were for generic drugs. CMS names the drug for 52 of them, across 3 drugs with 11 or more claims each, at $510 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kawsara for performance year 2024, reported through an alternative payment model (APM). Dr. Kawsara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of coronary angioplasty and stenting by Dr. Kawsara, more than 63% of the clinicians it reports for that procedure.

CMS Open Payments shows 184 general payments to Dr. Kawsara from 25 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 50% of the total. Medtronic, Inc. paid the most, $3,080. It also lists 3 research payments totaling $250 from 2017 to 2023.

Dr. Kawsara graduated from University of Aleppo Faculty of Medicine in 2006.

Dr. Kawsara is in network with 24 carriers, including Aetna, Elevance and Highmark. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.